- Home
- ARCB vs GH Comparison
ARCB vs GH Comparison
Compare ARCB & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCB
- GH
- Stock Information
- Founded
- ARCB 1923
- GH 2011
- Country
- ARCB United States
- GH United States
- Employees
- ARCB N/A
- GH N/A
- Industry
- ARCB Trucking Freight/Courier Services
- GH Medical Specialities
- Sector
- ARCB Industrials
- GH Health Care
- Exchange
- ARCB Nasdaq
- GH Nasdaq
- Market Cap
- ARCB 2.4B
- GH 2.7B
- IPO Year
- ARCB N/A
- GH 2018
- Fundamental
- Price
- ARCB $104.89
- GH $20.68
- Analyst Decision
- ARCB Buy
- GH Strong Buy
- Analyst Count
- ARCB 14
- GH 16
- Target Price
- ARCB $133.85
- GH $39.67
- AVG Volume (30 Days)
- ARCB 257.6K
- GH 1.6M
- Earning Date
- ARCB 11-01-2024
- GH 11-06-2024
- Dividend Yield
- ARCB 0.46%
- GH N/A
- EPS Growth
- ARCB N/A
- GH N/A
- EPS
- ARCB 5.30
- GH N/A
- Revenue
- ARCB $4,332,135,000.00
- GH $643,810,000.00
- Revenue This Year
- ARCB N/A
- GH $27.01
- Revenue Next Year
- ARCB $6.19
- GH $18.30
- P/E Ratio
- ARCB $19.71
- GH N/A
- Revenue Growth
- ARCB N/A
- GH 26.20
- 52 Week Low
- ARCB $86.93
- GH $15.81
- 52 Week High
- ARCB $153.60
- GH $37.04
- Technical
- Relative Strength Index (RSI)
- ARCB 49.14
- GH 33.92
- Support Level
- ARCB $101.15
- GH $20.36
- Resistance Level
- ARCB $109.54
- GH $21.95
- Average True Range (ATR)
- ARCB 3.50
- GH 0.74
- MACD
- ARCB 0.23
- GH 0.11
- Stochastic Oscillator
- ARCB 45.88
- GH 16.56
About ARCB ArcBest Corporation
ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.